AstraZeneca hosts R&D and VC Days in Boston

AstraZeneca leaders traveled to the company’s research facility in Boston this week to meet with representatives of venture capital firms and academic institutions who are interested in learning more about the company’s partnering goals. Our business model is driven by investment in innovative, prescription-based biopharmaceutical R&D. But the pace of scientific and technological advance means that companies like ours can no longer always go it alone. More than ever before, we are looking beyond our own laboratories to find partners with complementary skills and common goals. In fact, we are aiming for… Read More